About Aspira Diagnostics
Aspira Diagnostics is a company based in Mumbai (India) founded in 2015. The company has 70 employees as of December 20, 2024. Aspira Diagnostics offers products and services including Pathology Test, Sonography, X-Ray, and Health Packages. Aspira Diagnostics operates in a competitive market with competitors including Dr Lal PathLabs, Redcliffe Labs, Sterling Accuris Diagnostics, Orange health and Metropolis India, among others.
- Headquarter Mumbai, India
- Employees 70 as on 20 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aspira Pathlab & Diagnostics Ltd.
-
Annual Revenue
$2.57 M (USD)66.6as on Mar 31, 2024
-
Net Profit
$236.33 K (USD)175.71as on Mar 31, 2024
-
EBITDA
$415.54 K (USD)399.66as on Mar 31, 2024
-
Latest Funding Round
$401.26 K (USD), Post-IPO
Nov 28, 2019
-
Investors
-
Employee Count
70
as on Dec 20, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aspira Diagnostics
Aspira Diagnostics is a publicly listed company on the BSE with ticker symbol ASPIRA in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aspira Diagnostics
Aspira Diagnostics offers a comprehensive portfolio of products and services, including Pathology Test, Sonography, X-Ray, and Health Packages.
Laboratory analysis of blood and samples for health diagnosis
Ultrasound scans for detecting internal medical conditions
Radiographic exams for bone and tissue evaluation
Predefined tests for profiles like fever or monsoon-related issues
Funding Insights of Aspira Diagnostics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $401,258
-
First Round
First Round
(28 Nov 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Post-IPO - Aspira Diagnostics | Valuation |
investors |
|
Investments & Acquisitions by Aspira Diagnostics
Financial Statements - Aspira Diagnostics
Aspira Diagnostics Comparisons
Competitors of Aspira Diagnostics
Aspira Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dr Lal PathLabs, Redcliffe Labs, Sterling Accuris Diagnostics, Orange health and Metropolis India, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chain of pathology and radiology labs
|
|
| domain | founded_year | HQ Location |
Home-based diagnostic tests are booked via an online platform.
|
|
| domain | founded_year | HQ Location |
Pathology diagnostic services are offered via a chain of labs.
|
|
| domain | founded_year | HQ Location |
At-home diagnostic tests are booked and collected by phlebotomists.
|
|
| domain | founded_year | HQ Location |
Diagnostic centers are operated as a nationwide chain.
|
|
| domain | founded_year | HQ Location |
Leading diagnostic chain providing quality blood test and full body checkup services
|
Frequently Asked Questions about Aspira Diagnostics
Aspira Diagnostics was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Aspira Diagnostics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Chander Puri is the current CEO of Aspira Diagnostics.
As of Dec 20, 2024, the latest employee count at Aspira Diagnostics is 70.
Annual revenue of Aspira Diagnostics is $2.57M as on Mar 31, 2024.
Aspira was founded in 2015 and is based in Mumbai, India. The company operates as a chain of pathology labs focused on diagnostic services. Core activities include laboratory testing and pathology diagnostics, with operations centered in the healthcare sector. The domain aspiradiagnostics.com is used for its online presence. Leadership is provided by CEO Chander Puri.
Aspira Diagnostics's top competitors include Dr Lal PathLabs, Redcliffe Labs and Metropolis India.
Aspira Diagnostics offers Pathology Test, Sonography, X-Ray, and Health Packages.
Yes, Aspira Diagnostics is publicly traded on BSE under the ticker symbol ASPIRA.
The ticker symbol of Aspira Diagnostics is ASPIRA on BSE.